April 9, 2025 - 07:06

US Treasuries experienced a decline for the second consecutive day, following a disappointing auction of $58 billion in three-year government debt. The auction, which aimed to attract buyers for this crucial segment of the debt market, fell short of expectations, raising concerns among investors about the overall health of the economy and the appetite for government bonds.
The lackluster demand was evident as the bid-to-cover ratio, a key indicator of auction interest, dropped significantly. This has led to increased anxiety among market participants, who are now questioning the sustainability of recent bond yields and the potential implications for future monetary policy. Analysts suggest that the weak auction results may signal broader issues, including inflationary pressures and the Federal Reserve's ongoing adjustments to interest rates.
As market sentiment shifts, investors are keeping a close eye on upcoming economic data releases that could further influence the trajectory of US Treasuries and overall market stability.
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...